Specialties

Diabetes stigma in healthcare, especially when conveyed through subtle or unintentional language, can erode trust between clinicians and patients, reduce engagement in self‑management, and ultimately worsen outcomes. Yet many healthcare providers may not even realize how the words they use can have lasting effects on patient motivation and behavior. What …

As more patients with diabetes achieve and maintain glycemic targets, the conversation is shifting from “how can we intensify therapy?” to “when is it safe and appropriate to de‑intensify diabetes therapy?” De‑intensify diabetes therapy is becoming a high‑value clinical goal for many clinicians caring for adults with type 2 diabetes, …

In clinical practice, caring for a diabetes in aging population goes far beyond optimizing hemoglobin A1C. While glycemic control remains central, older adults with diabetes often face unique challenges such as sarcopenia, increased risk of falls, and progressive loss of functional independence. How can clinicians proactively identify these risks and …

Early in training, many clinicians learn the classic “eye–kidney–foot” framework for recognizing and managing complications of diabetes. However, as science advances, the range of recognized consequences of diabetes—and opportunities for earlier intervention—continues to broaden. Today, the concept of diabetes complications screening must evolve to include conditions such as metabolic dysfunction–associated …

Clinicians and care teams are increasingly focused on GLP‑1 receptor agonists, but SGLT2 inhibitors and metformin in diabetes management remain foundational in achieving comprehensive, evidence‑based outcomes. While GLP‑1 therapies generate headlines for weight loss and glucose control, 2025 guidelines still strongly emphasize the cardioprotective and renoprotective benefits of SGLT2 inhibitors …

Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …

The class of medications known as GLP-1 receptor agonists — commonly prescribed for type 2 diabetes and increasingly used for weight loss — may offer more than just metabolic benefits. Growing evidence indicates that GLP-1 drugs could play a role in protecting the brain. Could this mean a dual benefit …

Explore the vital link between heart disease and diabetes to empower patients in managing their health with informed strategies and preventive care.

Clinicians must inform patients about diabetic neuropathy risks, symptoms, and management to prevent complications and enhance quality of life.

Explore comprehensive insights into diabetic neuropathy for healthcare professionals, focusing on diagnosis, pathophysiology, and effective management strategies.